BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4204611)

  • 21. [On the therapy of the "dry eye" with bromhexidine HC1-drops (author's transl)].
    Thumm HW
    Klin Monbl Augenheilkd; 1978 Feb; 172(2):200-3. PubMed ID: 347159
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antimicrobial agents in eyedrops].
    Sklubalová Z
    Ceska Slov Farm; 2004 May; 53(3):107-16. PubMed ID: 15218731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Open drops in ophthalmology offices: expiration and contamination.
    Wessels IF; Bekendam P; Calvin WS; Zimmerman GJ
    Ophthalmic Surg Lasers; 1999; 30(7):540-6. PubMed ID: 10929977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fungal contamination of balanced salt solution.
    Isenberg RA; Weiss RL; Apple DJ; Lowrey DB
    J Am Intraocul Implant Soc; 1985 Sep; 11(5):485-6. PubMed ID: 4044390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On the suitability of septonex for the preservation of eyedrops].
    Hädicke M
    Pharm Prax; 1968; 6():161-2. PubMed ID: 5709459
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experience in the preparation of eye drops].
    Hentschel H
    Pharm Prax; 1970 Oct; 10():237-40. PubMed ID: 5492665
    [No Abstract]   [Full Text] [Related]  

  • 27. Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus.
    Karampatakis V; Papanikolaou T; Giannousis M; Goulas A; Mandraveli K; Kilmpasani M; Alexiou-Daniel S; Mirtsou-Fidani V
    Acta Ophthalmol; 2009 Aug; 87(5):555-8. PubMed ID: 18700884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contamination of eye drops by fungi].
    Aoki K
    Ganka; 1966 Aug; 8(8):683-6. PubMed ID: 6008891
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prolonged-action gentamycin sulfate eyedrops].
    Kutskaia IP; Golubev VN; Koroleva VG; Lobuseva AN
    Antibiotiki; 1981 Jan; 26(1):60-4. PubMed ID: 7212685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of the chemical stability of various mitomycin C solutions used in glaucoma filtering surgery.
    Francoeur AM; Assalian A; Lesk MR; Morin I; Tétreault F; Calleja K; Guttman A; Rauth M; Pan SS
    J Glaucoma; 1999 Aug; 8(4):242-6. PubMed ID: 10464732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibiotic stability in magistral collyria].
    Tihărău A; Voiculescu E; Vancea S; Teodorescu A; Cherecheş S
    Oftalmologia; 1990; 34(2):97-104. PubMed ID: 2101048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of oxytetracycline hydrochloride in eye-drops, prepared in pharmacies.
    Izer K; Török I; Pintér-Magyar G
    Acta Pharm Hung; 1994 Mar; 64(2):63-6. PubMed ID: 8017210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial Effectiveness in Eye Drops: Limited Sterility versus Reduction in Microbial Count.
    Abu Shaqra QM; Al-Groom RM; Abu Shaqra AQ
    PDA J Pharm Sci Technol; 2020; 74(3):309-317. PubMed ID: 31941794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ophthalmic lyophilisate carrier system (OLCS): development of a novel dosage form, freeze-drying technique, and in vitro quality control tests.
    Süverkrüp R; Grunthal S; Krasichkova O; Maier S; Weichselbaum A; Neff B; Diestelhorst M; Dinslage S; Lux A
    Eur J Pharm Biopharm; 2004 Mar; 57(2):269-77. PubMed ID: 15018984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stability of rifampicin in eyedrops].
    Izer K; Török I; Magyarné Pintér G; Varsányi LE; Lipták J
    Acta Pharm Hung; 1996 Jul; 66(4):157-63. PubMed ID: 9082836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of additives and storage temperature on physicochemical and microbiological properties of eye drops containing ceftazidime.
    Kodym A; Zawisza T; Napierała B; Kukuła H
    Acta Pol Pharm; 2006; 63(6):507-13. PubMed ID: 17438868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time- and temperature-dependent stability of growth factor peptides in human autologous serum eye drops.
    Bradley JC; Simoni J; Bradley RH; McCartney DL; Brown SM
    Cornea; 2009 Feb; 28(2):200-5. PubMed ID: 19158565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Considerations for the control of ophthalmic tubes with aluminum varnish].
    Herman F; Aerts A; Alexis J; Barbe ; Baudon P; Delattre L; Leloup J; Stein E; Van den Eeckhout E
    J Pharm Belg; 1972; 27(4):480-92. PubMed ID: 4681078
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of the stability and storage time of eyedrops--solutions of pilocarpine hydrochloride, atropine sulfate and scopolamine hydrobromide].
    Zelikson IuI
    Farmatsiia; 1969; 18(1):23-7. PubMed ID: 5770766
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on in-use microbial contamination of eye drops.
    Aslund B; Olson OT; Sandell E
    Acta Pharm Suec; 1978; 15(5):389-94. PubMed ID: 747097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.